The overall purpose of the Survey Research Core (SRC) is to provide standardized services for conducting survey-based research. The SR(5 collects and manages survey-based research data for population-based studies. SRC utilizes a critical mass of highly trained personnel to maximize efficiency, reduce the cost and optimize participation rates from survey-based research. The Core services include: i) sample selection; ii) survey design and pre-testing; iii) implementing and monitoring mailed surveys; iv) conducting all aspects of telephone survey; v) implementation of all aspects of web-based survey; vi) tracking study subjects lost to follow-up; and vii) automated data entry. The SRC is located in the Department of Population Sciences that houses the vast majority of the Cancer Control and Population Sciences (CCPS) members. While the SRC serves primarily the members of the CCPS Program, it has also provided services to members of the Hematological Malignancies, and Developmental Cancer Therapeutics Programs interested in conducting research utilizing mailed, web-based, or telephone surveys for collecting exposure or outcome data. Dr. Can- Lan Sun has directed the Core since its inception in 2006. The staff of the SRC includes one Clinical Research Associate, and one MS-prepared Biostatistician, with close collaboration with and supervision by the Ph.D.-level Biostatistician. In order to handling mass mailing surveys and collecting high-quality data, the SRC utilizes Cardiff Teleform Information Capture System, an automated content capture system, and the DatStat Illume integrated platform to conduct web-based surveys. Since December 2007, SRC services have been utilized by 40 studies, resulting in the development of over 150 forms. The vast majority of the core's time has been spent on scannable form design/on-line survey design, scanning/ verification and database management Services provided by the SRC have resulted in several high impact publications.
The overall goal of the Survey Research core facility is to conduct survey-based research to obtain data for population-based studies. The facility uses highly trained personnel and assist in sample selection, survey design, conduct surveys via phone and web, track study subjects for follow-up and develop automated data entry. This goal enhances the Cancer Center's dedication to developing innovative new disease-fighting strategies in the battle against cancer.
|Gu, Ying; Zhang, Jiawei; Ma, Xiaoxiao et al. (2017) Stabilization of the c-Myc Protein by CAMKII? Promotes T Cell Lymphoma. Cancer Cell 32:115-128.e7|
|Cao, Pengpeng; Mooney, Rachael; Tirughana, Revathiswari et al. (2017) Intraperitoneal Administration of Neural Stem Cell-Nanoparticle Conjugates Targets Chemotherapy to Ovarian Tumors. Bioconjug Chem 28:1767-1776|
|Mohanty, Suchismita; Mohanty, Atish; Sandoval, Natalie et al. (2017) Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines. Leuk Lymphoma 58:676-688|
|Wittenberg, Elaine; Ferrell, Betty; Koczywas, Marianna et al. (2017) Pilot Study of a Communication Coaching Telephone Intervention for Lung Cancer Caregivers. Cancer Nurs :|
|Yuan, Yuan; Vora, Nilesh; Sun, Can-Lan et al. (2017) Association of Pre-Chemotherapy Peripheral Blood Pro-Inflammatory and Coagulation Factors with Physical Function in Women with Breast Cancer. Oncologist 22:1189-1196|
|Deng, Ruishu; Hurtz, Christian; Song, Qingxiao et al. (2017) Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease. Nat Commun 8:978|
|He, Zhiheng; Ma, Jian; Wang, Ruiqing et al. (2017) A two-amino-acid substitution in the transcription factor ROR?t disrupts its function in TH17 differentiation but not in thymocyte development. Nat Immunol 18:1128-1138|
|Kortylewski, Marcin; Moreira, Dayson (2017) Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities. Cancer Immunol Immunother 66:979-988|
|Somlo, George; Frankel, Paul H; Arun, Banu K et al. (2017) Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083. Clin Cancer Res 23:4066-4076|
|Slavin, Thomas P; Neuhausen, Susan L; Nehoray, Bita et al. (2017) The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes. Fam Cancer :|
Showing the most recent 10 out of 1277 publications